Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease - Oligonucleotide Therapeutics Society

Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson’s disease

AUTHOR

OTS

DATE

January 30, 2021

CATEGORIES

antisense,Delivery,Medicinal Chemistry,Ribozyme

SHARE

Post Views: 597

Yang J, Luo S, Zhang J, Yu T, Fu Z, Zheng Y, Xu X, Liu C, Fan M, Zhang Z.

Neurobiol Dis. Epub 2020 Dec 6.

Related articles

Subscribe to our Newsletter

OTS_Logo_retina

Oligonucleotide Therapeutics Society

c/o Event Innovations, Inc.
4377 Newport Avenue
San Diego, CA 92107, USA

(619) 795-9458
info@oligotherapeutics.org

Resources

Stay Connected

Search

Subscribe in a reader

© Copyright 2012 – 2022 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing

Username/Email Address:
Password:
Forgot Password? | Sign Up

Save Password

First Name *
Last Name *
Username *
Email *
Password *
Confirm Password *
Phone:
Organization Name
Select Sectors
By clicking checkbox, you agree to our Terms and Conditions and Privacy Policy

Already have an account? Login